Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) Share Price

Company Profile

Business description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalosporins, and bone resorption inhibitors. Its products mainly focus on the areas of cardio-cerebral vascular disease, diabetes, complications, anti-tumor, and orthopedics. Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Contact
No. 6009, Shennan Avenue
37th Floor, Main Building, Tower B
Chegongmiao Greenview Plaza
Futian District
Shenzhen518040
CHN
T: +86 75583867888
https://www.salubris.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
3,596

Recommended

Expense guidance changes short-term earnings but not long-term fundamentals.

Roy Van Keulen | 28 January 2026

Read the latest take from our analysts.

Simonelle Mody | 28 January 2026

From cloud computing growth to AI monetization, here’s what we’re looking for in Alphabet’s upcoming earnings report.

Malik Ahmed Khan, CFA | 28 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,171.10	72.20	-0.78%
CAC 40	8,066.68	86.14	-1.06%
DAX 40	24,822.79	71.65	-0.29%
Dow JONES (US)	49,015.60	12.19	0.02%
FTSE 100	10,154.43	53.37	-0.52%
HKSE	27,763.58	63.33	-0.23%
NASDAQ	23,857.45	40.35	0.17%
Nikkei 225	53,255.76	102.95	-0.19%
NZX 50 Index	13,347.40	65.47	-0.49%
S&P 500	6,978.03	0.57	-0.01%
S&P/ASX 200	8,866.40	56.80	-0.64%
SSE Composite Index	4,140.18	11.05	-0.27%